Medical Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

Jul 20, 2017, 09:00 ET NYU Langone Hospital - Brooklyn Receives $25 Million Gift From the Bezos Family Foundation

NYU Langone Hospital – Brooklyn, formerly NYU Lutheran Medical Center, announced a new name and a major philanthropic gift, marking a significant...


Jul 20, 2017, 09:00 ET ZappRx Launches Specialty Drug Prescribing Platform at Arizona Pulmonary Specialists and Harbor-UCLA Medical Center

ZappRx, a digital health company that reduces the administrative burden associated with prescribing specialty medications, today announced that its...


Jul 20, 2017, 09:00 ET Canadian Regulatory Authority Approves Powerheart® G5 Automatic AED

Cardiac Science, a leading global manufacturer of potentially life-saving automated external defibrillators (AEDs), announced today that it has...


Jul 20, 2017, 08:30 ET 5 Standout Legal Cannabis Companies Worthy of Consideration

The legal marijuana market continues to gain momentum, driven by increasing public acceptance and an increasing number of investors looking for...


Jul 20, 2017, 08:30 ET Mesothelioma Victims Center Now Urges a Veteran With Mesothelioma Because of Asbestos Exposure on a US Navy Aircraft Carrier to Call About the Nation's Top Lawyers for Compensation

The Mesothelioma Victims Center says, "We are committed to making certain a Navy Veteran with confirmed mesothelioma has on-the-spot...


Jul 20, 2017, 08:30 ET First Patients Treated with ViewRay's MRIdian Linac System at Henry Ford Health System

ViewRay, Inc. (Nasdaq: VRAY) announced today that the first cancer patients have been treated using the company's MRIdian Linac system at Henry...


Jul 20, 2017, 08:30 ET New Research Details Risk of National OB-GYN Shortage

Doximity, the leading social network for physicians and advanced practice clinicians, released a report today on an impending women's health...


Jul 20, 2017, 08:30 ET Exploragen Creates DNA-based Lifestyle Apps

Exploragen has launched as a DNA lifestyle company to deliver useful DNA-based apps directly to consumers. The new California startup, led by a...


Jul 20, 2017, 08:09 ET New Peer-Reviewed Study Shows Livongo Decreases Likelihood of High and Low Blood Glucose Readings

According to a new study published in the peer-reviewed Journal of Medical Internet Research (JMIR), Livongo members experienced a decreased...


Jul 20, 2017, 08:06 ET Pharma IQ: 16th Annual Laboratory Informatics Summit

World's Most Comprehensive Software Informatics Forum Laboratory Informatics, taking place in Amsterdam on the 19th - 21st September is Europe's...


Jul 20, 2017, 08:02 ET Doctors' Demand for Omnipresent Engagement Accelerates

The gap between doctors' preference for in-person engagement and digital engagement is fast closing. A new global analysis, "The Digital Savvy HCP...


Jul 20, 2017, 08:00 ET FDAnews Joins WIRB-Copernicus Group

WIRB-Copernicus Group (WCG), the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research,...


Jul 20, 2017, 08:00 ET CureVac to Receive Patent Claiming the Combination of mRNA Vaccines with Anti-PD-1 Antibodies

CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced it has been granted a Notice of...


Jul 20, 2017, 08:00 ET Imprimis Pharmaceuticals Announces $16 Million Debt Facility with SWK Holdings

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today announced it has entered into a $16 million...


Jul 20, 2017, 08:00 ET U.S. FDA Grants Orphan-Drug Designation to Astellas for Development of FLT3 Inhibitor Gilteritinib in Acute Myeloid Leukemia

Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") announced today that the U.S. Food and Drug Administration...


Jul 20, 2017, 08:00 ET Gamida Cell Announces $3.5 Million Grant from the Israeli Government

Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that it has been...


Jul 20, 2017, 08:00 ET Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA™ by the U.S. FDA

Churchill Pharmaceuticals, LLC (Churchill), a privately held company devoted to expanding treatment options with oral oncology agents, announces...


Jul 20, 2017, 08:00 ET Genomic Health to Announce Second Quarter 2017 Financial Results and Host Conference Call on Tuesday, August 1, 2017

Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Tuesday, August 1 at 4:30 p.m....


Jul 20, 2017, 08:00 ET Applied Silver Appoints Two New Advisors

Applied Silver, the maker of SilvaClean™ Antimicrobial Treatment, today announced the appointment of Christopher Dawes and Dr. David M. Joyner as...


Jul 20, 2017, 07:45 ET Abbott Reports Second-Quarter 2017 Results

Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2017. - Second-quarter worldwide sales of $6.6...


Jul 20, 2017, 07:30 ET Une nouvelle étude montre la supériorité du système TomoTherapy® sur la technique RapidArc® en termes de contrôle local dans les cancers de la tête et du cou

Cette étude prospective multicentrique, financée par l'Institut National du Cancer (INCa), démontre également qu'un traitement par TomoTherapy...


Jul 20, 2017, 07:30 ET New Data Show TomoTherapy® System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers

Accuray Incorporated (NASDAQ: ARAY) announced today that a prospective study conducted at 14 French centers showed the clinical benefits of...


Jul 20, 2017, 07:18 ET Dr. Ken Kolb Joins RxEOB as Vice President of Pharmacy Analytics

RxEOB, an industry leader in member engagement applications for pharmacy benefits, has added Dr. Ken Kolb of Richmond to their growing team as vice...


Jul 20, 2017, 07:15 ET Global Leukemia Therapeutics Market to Reach $2.6 Billion by 2025 - Increasing Research & Development in Leukemia Therapeutics

The "Global Leukemia Therapeutics Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets'...


Jul 20, 2017, 07:00 ET Behandling av kronisk ryggsmärta i Umeå hos EuroPainClinics® Sverige

Nu erbjuds avancerad behandling av kronisk ryggsmärta i Umeå, på det nyöppnade integrerade centrumet för endoskopiska och minimalinvasiva...


Most Viewed